Symposia: Clonal Hematopoiesis, Aging, and Inflammation
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Fundamental Science, Research, Adult, Translational Research, CHIP, Elderly, Epidemiology, Genomics, Clinical Research, Hematopoiesis, Diseases, Metabolism, Lymphoid Malignancies, Biological Processes, Myeloid Malignancies, Survivorship, Technology and Procedures, Molecular biology, Gene editing, Study Population, Human, Animal model
Type: Oral
Hematology Disease Topics & Pathways:
Fundamental Science, Research, Adult, Translational Research, CHIP, Elderly, Epidemiology, Genomics, Clinical Research, Hematopoiesis, Diseases, Metabolism, Lymphoid Malignancies, Biological Processes, Myeloid Malignancies, Survivorship, Technology and Procedures, Molecular biology, Gene editing, Study Population, Human, Animal model
Monday, December 9, 2024: 4:30 PM-6:00 PM
Grand Hall C
(Manchester Grand Hyatt San Diego)
Moderators:
Lachelle D. Weeks, MD, PhD, Dana Farber Cancer Institute
and
Catherine C. Coombs, MD, University of North Carolina
Disclosures:
Coombs: AbbVie: Consultancy, Honoraria, Research Funding, Speakers Bureau; AstraZeneca: Consultancy, Honoraria, Speakers Bureau; Beigene: Consultancy, Honoraria, Research Funding, Speakers Bureau; Lilly: Consultancy, Honoraria, Research Funding, Speakers Bureau; Genentech: Consultancy, Honoraria, Speakers Bureau; Mingsight: Honoraria; Allogene: Honoraria; MEI Pharma: Honoraria; Janssen: Honoraria; Octapharma: Consultancy; Bluebird Bio: Current equity holder in publicly-traded company; Pfizer: Current equity holder in publicly-traded company; Geron: Current equity holder in publicly-traded company.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH